the activity of afatinib in lung cancer
Published 8 years ago • 645 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
8:38
afatinib plus cetuximab in resistant non-small cell lung cancer
-
1:53
dr. mok on the utility of afatinib in lung cancer
-
1:59
dr. tolba on the use of afatinib in nrg1-mutated lung adenocarcinoma
-
3:07
efficacy and safety of afatinib vs erlotinib and gefitinib in egfr nsclc
-
1:25
dr. bunn discusses afatinib in lung cancer
-
1:47
dr. west on fda approval of afatinib in nsclc with rare egfr mutations
-
5:43
tolerability-guided dose adjustment of afatinib in nsclc
-
3:47
afatinib therapy for uncommon egfr alterations in nsclc
-
6:46
selecting a first-line egfr inhibitor in nsclc
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
4:09
frontline afatinib in egfr-mutant nsclc
-
1:25
dr. chachoua on afatinib for exon 19 mutation in lung cancer
-
4:24
afatinib treatment in squamous cell lung cancer – video abstract [id 104177]
-
8:47
study of 693 nsclc patients treated with afatinib
-
17:27
how, when, and where to utilize erlotinib, afatinib, and gefitinib in egfr positive nsclc
-
5:47
egfr tkis for upfront treatment of nsclc
-
1:30
dr. langer on afatinib for advanced non-small cell lung cancer
-
1:35
afatinib for advanced egfrm-positive nsclc
-
1:35
dr. janjigian discusses afatinib and cetuximab for patients with egfr-mutant lung cancer